lupus nephritis
![Kezar Faces Significant Staff Loss, CEO Persists in Advancing Lead Lupus Candidate to Phase 2 Milestone](https://pharmtales.com/wp-content/uploads/2023/10/Kezar-Faces-Significant-Staff-Loss-CEO-Persists-in-Advancing-Lead-Lupus-Candidate-to-Phase-2-Milestone.jpg)
Kezar Faces Significant Staff Loss, CEO Persists in Advancing Lead Lupus Candidate to Phase 2 Milestone
Anika Sharma
Kezar Life Sciences is embarking on a significant restructuring plan aimed at preserving cash resources over the next two years ...